The kill-switch for CRISPR that could make gene-editing safer
Elie Dolgin • Jan 15, 2020
How anti-CRISPR proteins and other molecules could bolster biosecurity and improve medical treatments.
It started out as “sort of a stupid thing to do”, recalls Joe Bondy-Denomy, a microbiologist at the University of California, San Francisco.
Continue reading here.
Drug trial results show that vaccines aren't the only use for the mRNA technology behind the most widely used COVID-19 jabs.
FDA panel’s green light on glaucoma wearable device offers hope in sight.